The efficacy, safety, and rationale of orelabrutinib combined with obinutuzumab (O2) as a first-line systemic treatment for marginal zone lymphoma. [PDF]
Xu J +13 more
europepmc +1 more source
FcεRIγ reinforces double-negative T cell-mediated antibody-dependent cellular cytotoxicity against tumor cells. [PDF]
Shao S +13 more
europepmc +1 more source
Comparison of four different in vitro assays for prediction of potential RBC antibody clinical significance. [PDF]
Noa YR +6 more
europepmc +1 more source
Functional antibody responses and protection against symptomatic dengue. [PDF]
Chua CLL +5 more
europepmc +1 more source
NAV-005, a high-affinity MUC16/CA125 antagonist for the treatment of humoral immunosuppressed cancers. [PDF]
Nicolaides NC, Kline JB, Grasso L.
europepmc +1 more source
Bispecific antibody AP402 targets p95HER2 and induces costimulation through CD137 to improve efficacy for HER2-positive tumors. [PDF]
Huang PL +7 more
europepmc +1 more source
Plasmacytic markers as immunotherapeutic targets for primary CD20-negative aggressive B-cell lymphomas. [PDF]
Neumann F +13 more
europepmc +1 more source
Longitudinal assessment of functional antibodies to a novel influenza virus strain across age groups. [PDF]
Huckriede A +6 more
europepmc +1 more source
Fine Needle Aspiration Cytology of Adenomyoepithelioma of the Breast: Cytologic Findings and Histologic Correlations. [PDF]
Sakuma T, Kawahata K, Matsuo K.
europepmc +1 more source
Tumor Acidosis Boosts Antibody-Driven Cytotoxic Potential of Neutrophils. [PDF]
Holtrop T +9 more
europepmc +1 more source

